Waiting for the midterms
But pharmaceutical executives don’t appear comforted by the pushback. “Today it may be childhood vaccines or mRNA, but tomorrow it’s everything,” Noubar Afeyan, co-founder and chairman of Moderna, maker of mRNA vaccines, said. “We have to say not just ‘why is this happening?,’ but ‘Where will it stop?’”
As a bad flu season is underway, Dean Li, president of Merck Research Laboratories, noted that the anti-vaccine rhetoric is hitting seasonal flu shots. “With the pressure on vaccination, I cannot foresee flu vaccination increasing in this country over the next three years,” he said in a presentation.
Sanofi Chief Executive Paul Hudson had a similarly pessimistic
→ Continue reading at Ars Technica